Literature DB >> 16113378

Optical coherence tomography guided retreatment of photodynamic therapy.

I Krebs1, S Binder, U Stolba, K Schmid, C Glittenberg, W Brannath, A Goll.   

Abstract

AIM: To evaluate the results of a retreatment modality of photodynamic therapy (PDT) based on optical coherence tomography (OCT) and fluorescein angiography (FA). To quantify the effect of PDT with the help of measurement of the retinal thickness.
METHODS: Eyes with predominantly classic subfoveal choroidal neovascularisation (CNV) due to age related macular degeneration were included. PDT was performed every three months, when needed. OCT, FA, and measures of distance acuity were performed at baseline, after 6 weeks, 3 months, and from then on every 3 months. A control group of a consecutive series of eyes that had been retreated based only on FA results was installed.
RESULTS: Forty eyes of 38 patients were included. The average age was 73 years. The maximum retinal thickness decreased from 404 mum at baseline to 281.6 mum at month 12. Furthermore there was a significant decrease of retinal thickness in both subgroups. The number of retreatments was reduced, when activity was diagnosed using OCT and FA. (2.4 v 4.0). The distance acuity correlated significantly with the maximum retinal thickness (p=0.0042).
CONCLUSION: Information about the activity of a neovascular lesion can be obtained with the help of OCT. The retreatment modalities can be optimised by using OCT and FA and the number of retreatments can be reduced.

Entities:  

Mesh:

Year:  2005        PMID: 16113378      PMCID: PMC1772806          DOI: 10.1136/bjo.2005.067389

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  20 in total

1.  Intersession repeatability of macular thickness measurements with the Humphrey 2000 OCT.

Authors:  D Koozekanani; C Roberts; S E Katz; E E Herderick
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-05       Impact factor: 4.799

2.  Optical coherence tomography findings following photodynamic therapy of choroidal neovascularization.

Authors:  Adam H Rogers; Adam Martidis; Paul B Greenberg; Carmen A Puliafito
Journal:  Am J Ophthalmol       Date:  2002-10       Impact factor: 5.258

3.  Optical coherence tomography of age-related macular degeneration and choroidal neovascularization.

Authors:  M R Hee; C R Baumal; C A Puliafito; J S Duker; E Reichel; J R Wilkins; J G Coker; J S Schuman; E A Swanson; J G Fujimoto
Journal:  Ophthalmology       Date:  1996-08       Impact factor: 12.079

4.  Surgical removal of subfoveal choroidal neovascularization: visual outcome and prognostic value of fluorescein angiography and optical coherence tomography.

Authors:  C Brindeau; A Glacet-Bernard; F Coscas; G Mimoun; L Boukhli; G Coscas; G Soubrane
Journal:  Eur J Ophthalmol       Date:  2001 Jul-Sep       Impact factor: 2.597

5.  Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1999-10

6.  Intravitreal triamcinolone for refractory diabetic macular edema.

Authors:  Adam Martidis; Jay S Duker; Paul B Greenberg; Adam H Rogers; Carmen A Puliafito; Elias Reichel; Caroline Baumal
Journal:  Ophthalmology       Date:  2002-05       Impact factor: 12.079

7.  Reproducibility of retinal mapping using optical coherence tomography.

Authors:  P Massin; E Vicaut; B Haouchine; A Erginay; M Paques; A Gaudric
Journal:  Arch Ophthalmol       Date:  2001-08

8.  Photodynamic effects on choroidal neovascularization and physiological choroid.

Authors:  Ursula Schmidt-Erfurth; Stephan Michels; Irene Barbazetto; Horst Laqua
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-03       Impact factor: 4.799

9.  Choroidal neovascular membranes: reproducibility of angiographic interpretation.

Authors:  S M Friedman; C E Margo
Journal:  Am J Ophthalmol       Date:  2000-12       Impact factor: 5.258

10.  Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.

Authors:  N M Bressler
Journal:  Arch Ophthalmol       Date:  2001-02
View more
  10 in total

Review 1.  Imaging and photodynamic therapy: mechanisms, monitoring, and optimization.

Authors:  Jonathan P Celli; Bryan Q Spring; Imran Rizvi; Conor L Evans; Kimberley S Samkoe; Sarika Verma; Brian W Pogue; Tayyaba Hasan
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

2.  Optical coherence tomography analysis of a randomized study combining photodynamic therapy with intravitreal triamcinolone.

Authors:  L Arias; J Garcia-Arumi; J M Ramon; M Badia; M Rubio; O Pujol
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-08-03       Impact factor: 3.117

3.  Prognosis of untreated occult choroidal neovascularization.

Authors:  Ilse Krebs; Ulrike Stolba; Carl Glittenberg; Orang Seyeddain; Thomas Benesch; Susanne Binder
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-10-27       Impact factor: 3.117

4.  Early visual impacts of optical coherence tomographic parameters in patients with age-related macular degeneration following the first versus repeated ranibizumab injection.

Authors:  Khulood Mohammed Sayed; Takeshi Naito; Toshihiko Nagasawa; Takashi Katome; Yoshinori Mitamura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-04-15       Impact factor: 3.117

5.  A new treatment regimen in combined intravitreal injection of triamcinolone acetonide and photodynamic therapy.

Authors:  Ilse Krebs; Susanne Binder; Ulrike Stolba
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-12-06       Impact factor: 3.117

6.  Predictors of response after intravitreal bevacizumab injection for neovascular age-related macular degeneration.

Authors:  Yeo Jue Byun; Sung Jun Lee; Hyoung Jun Koh
Journal:  Jpn J Ophthalmol       Date:  2010-12-30       Impact factor: 2.447

7.  Relationship between optical coherence tomography retinal parameters and visual acuity in neovascular age-related macular degeneration.

Authors:  Pearse A Keane; Sandra Liakopoulos; Karen T Chang; Mingwu Wang; Laurie Dustin; Alexander C Walsh; Srinivas R Sadda
Journal:  Ophthalmology       Date:  2008-10-18       Impact factor: 12.079

8.  Activity of neovascular lesions treated with bevacizumab: comparison between optical coherence tomography and fluorescein angiography.

Authors:  Ilse Krebs; Siamak Ansari-Shahrezaei; Alexandra Goll; Susanne Binder
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-01-15       Impact factor: 3.117

9.  In-vivo investigation of laser-induced choroidal neovascularization in rat using spectral-domain optical coherence tomography (SD-OCT).

Authors:  Tao Liu; Ling Hui; Yu-sheng Wang; Jian-qiang Guo; Rong Li; Jing-bo Su; Jian-kang Chen; Xue-mei Xin; Wei-hua Li
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-11-01       Impact factor: 3.117

10.  Photodynamic therapy monitoring with optical coherence angiography.

Authors:  M A Sirotkina; L A Matveev; M V Shirmanova; V Y Zaitsev; N L Buyanova; V V Elagin; G V Gelikonov; S S Kuznetsov; E B Kiseleva; A A Moiseev; S V Gamayunov; E V Zagaynova; F I Feldchtein; A Vitkin; N D Gladkova
Journal:  Sci Rep       Date:  2017-02-02       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.